Key facts
- This page summarizes Charles Theuer's Form 4 filing for 4D Molecular Therapeutics, Inc. (FDMT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Dec 2025, 16:35.
Charles Theuer - 12 Dec 2025 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)
- Reporting relationship
- Director
- Issuer ticker
- FDMT
- Reported as of
- 12 Dec 2025
- Net transaction value
- +$10,640
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2025, 16:35:36 UTC
- Prior SEC filing
- 20 Jun 2025
- Next SEC filing
- 18 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Scott Bizily as Attorney-in-Fact for Charles Theuer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles Theuer filed Form 4 for 4D Molecular Therapeutics, Inc. (FDMT) on 16 Dec 2025.
Change
- Previous filing in this sequence was filed on 20 Jun 2025.
- Current net transaction value: +$10,640.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001631338
Primary reporting owner
THEUER CHARLES
- Relationship
- Director
- Address
- C/O 4D MOLECULAR THERAPEUTICS, INC., 5858 HORTON STREET #455, EMERYVILLE
- Signature
- /s/ Scott Bizily as Attorney-in-Fact for Charles Theuer
- Signature date
- 16 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FDMT
transaction
Common Stock
Options Exercise
- Transaction value
- $10,640
- Shares
- +9,333
- Change %
- +29%
- Price
- $1.14
- Shares after
- 41,684
- Date
- 12 Dec 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FDMT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -9,333
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 12 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,333
- Exercise price
- $1.14
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Fully vested.